2012 Global Mycoplasma Diagnostics Market Outlook: Test Volumes, Sales Forecasts, and Supplier Shares by Country

Date: April 20, 2012
Pages: 202
Price:
US$ 3,850.00 US$ 3,272.50
License [?]:
Publisher: VPGMarketResearch.com
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: G347BD535E4EN
Leaflet:

Download PDF Leaflet

2012 Global Mycoplasma Diagnostics Market Outlook: Test Volumes, Sales Forecasts, and Supplier Shares by Country
The report presents a detailed analysis of the Mycoplasma diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Mycoplasma definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments:
  • Hospitals
  • Commercial/Private Labs
  • Physician Offices
  • Public Health Labs
For each country, in addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of Mycoplasma tests.

Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns.

Contains 202 pages and 15 tables.
I. INTRODUCTION

II. WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW


A. Background
  Ureaplasma Urealyticum & Mycoplasma Hominis
B. Diagnostic Tests
C. Vaccines and Drugs
D. Emerging Diagnostic Technologies
  1. DNA Probes
    a. Technology Overview
    b. Amplification Methods
      Polymerase Chain Reaction
        Robotics
        Temperature Cyclers
        PCR Variations
      Immuno-PCR
      QC-PCR
      DAP-PCR
      Ligase Chain Reaction
      Branched DNA
      Q-Beta Replicase
      Nucleic-Acid Sequence-Based
      Strand Displacement Activation
      Self-Sustained Sequence Replicase
  2. Monoclonal Antibodies
  3. Immunoassays
    a. Technological Principle
    b. Enzyme Immunoassays (EIA)
      Overview
      ELISA
      Dot Immunobinding Assays
      Capillary Immunoassays
      Particle-Membrane Capture Immunoassays
      Enzyme Amplification
    c. Fluorescent Immunoassays
      Fluorescence Polarization
      Time-Resolved Pulse Fluorescence
    d. Luminescence
      Chemiluminescence
      Bioluminescence
    e. Latex Agglutination
    f. Immunoprecipitation
  4. Differential Light Scattering
  5. Microcomputers and Automation
  6. Artificial Intelligence
  7. Liposomes
  8. Flow Cytometry
  9. Chromatography
  10. MRI
  11. Gel Microdroplets
  12. Other

III. FRANCE: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES

IV. GERMANY: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES

V. ITALY: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES

VI. JAPAN: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES

VII. SPAIN: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES

VIII. UK: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES

IX. USA: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES

X. ALTERNATIVE MARKET PENETRATION STRATEGIES


A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
  1. Marketing Approaches
  2. Product Complexity
  3. Customer Preference
  4. Established Suppliers
  5. Emerging Suppliers
  6. Major Types of Distributors
  7. Market Segmentation

XI. POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

XII. COMPETITIVE ASSESSMENTS

  Abbott
  Affymetrix
  Applera
  Beckman Coulter
  Becton Dickinson
  Binding Site
  Biomerica
  Biokit
  bioMerieux
  Bio-Rad
  Biotrol
  Biosite
  Biotest
  Caliper Technologies
  Cepheid
  Chemicon
  Daiichi
  DiaSorin
  Diagast
  Diamedix
  Digene
  Eiken
  Enzo Biochem
  Fujirebio
  GenBio
  Gene-Tec
  Hemagen
  Immunetics
  Innogenetics
  Inverness
  J&J
  Meridian
  Nanogen
  Nissui
  Olympus
  Provalis
  Roche
  Saliva Diagnostic
  SeraCare
  Siemens
  Third Wave Technologies
  Thermo Fisher
  Tosho
  Trinity Biotech
  Tropix
  Wampole Labs
  Zenith
  Zeus

LIST OF TABLES

Major Companies Developing or Marketing Mycoplasma Tests
France Mycoplasma Test Volume and Diagnostics Sales Forecast by Market Segment
France Mycoplasma Testing Market Diagnostics Sales by Major Supplier
Germany Mycoplasma Test Volume and Diagnostics Sales Forecast by Market Segment
Germany Mycoplasma Testing Market Diagnostics Sales by Major Supplier
Italy Mycoplasma Test Volume and Diagnostics Sales Forecast by Market Segment
Italy Mycoplasma Testing Market Diagnostics Sales by Major Supplier
Japan Mycoplasma Test Volume and Diagnostics Sales Forecast by Market Segment
Japan Mycoplasma Testing Market Diagnostics Sales by Major Supplier
Spain Mycoplasma Test Volume and Diagnostics Sales Forecast by Market Segment
Spain Mycoplasma Testing Market Diagnostics Sales by Major Supplier
U.K. Mycoplasma Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Mycoplasma Testing Market Diagnostics Sales by Major Supplier
U.S.A. Mycoplasma Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Mycoplasma Testing Market Diagnostics Sales by Major Supplier
Skip to top


Ask Your Question

2012 Global Mycoplasma Diagnostics Market Outlook: Test Volumes, Sales Forecasts, and Supplier Shares by Country
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: